다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Principia Biopharma Inc (PRNB)
Principia Biopharma Inc (PRNB) 뉴스

PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PRNB

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/02/17	05:14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/11/24	22:00	GlobeNewswire Inc.	Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib	NASDAQ:PRNB	Principia Biopharma Inc
2020/10/08	20:01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:PRNB	Principia Biopharma Inc
2020/10/01	19:06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/29	06:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22:20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22:18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22:16	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	22:12	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	21:49	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	21:43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	19:35	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/28	19:31	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/22	19:44	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/22	19:32	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/17	21:01	GlobeNewswire Inc.	Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/15	05:34	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/10	23:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRNB	Principia Biopharma Inc
2020/09/10	21:00	GlobeNewswire Inc.	Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/28	14:44	Dow Jones News	Sanofi to Launch Tender Offer for Principia Acquisition	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/26	01:33	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	19:01	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/21	05:20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/20	02:50	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/18	19:01	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:PRNB	Principia Biopharma Inc
2020/08/18	16:02	Dow Jones News	Sanofi Buys MS-Drug Development Partner -- WSJ	NASDAQ:PRNB	Principia Biopharma Inc

검색 관련기사 보기:NASDAQ:PRNB

1 2 3 4 5 6 7 8 다음 >>

Citigroup Global Markets...

Telefonica Czech Republi... (CE)

PYR Token [Vulcan Forged]

Silver Range Resources (PK)

Morgan Stanley Finance L...

FCT Sapphireone Auto 202...

EZZ Life Science

Telewest Global

BNP Paribas Issuance

Innovator International ...

Global Indemnity

SPDR Bloomberg SASB Euro...

BNP Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관